Europe
MR Solutions shows new state-of-the-art bench top CT preclinical scanner with clip on PET and SPECT at nuclear medicine congress
CellGeni is pleased to announce the appointment of Dr. Udo Nirenberg as Vice President of Quality Management and member of the management team.
Oxurion NV announced today that it entered into a strategic research collaboration with Beta Therapeutics Pty Ltd
Phase 1 data show favourable safety profile
Crescendo Biologics Ltd today announces that Takeda Pharmaceutical Company Limited (Takeda), has exercised an option under its existing, multi-target collaboration and license agreement.
Interventions that promote healthy microbiome acquisition in infants key to curbing chronic childhood diseases
Method Provides new Insights into the Interaction between the Host and Intestinal Flora
Nouscom announced today that it has appointed John F. McDonald as an independent director to its Board of Directors.
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments designed to transform bone marrow transplantation for the treatment of blood diseases, announces that Andrew Wright has been appointed as Financial Controller & Company Secretary, a non-Board position, and that Lawrence Pemble, Chief Operating Officer, will step down from the Board, both with immediate effect.
Recipharm will publish its interim report for January-September 2018 on the 8th November at 07:45 am CET.
PRESS RELEASES